Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

TETRACYN

PROCAINE HYDROCHLORIDE; TETRACYCLINE HYDROCHLORIDE

Standard Dose
40MG/VIAL;100MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview TETRACYN is listed in Drugs@FDA under application 060285 (ANDA).

Marketing status: Discontinued Active ingredient PROCAINE HYDROCHLORIDE; TETRACYCLINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 40MG/VIAL;100MG/VIAL Sponsor PFIZER Submission history Latest submission status date: 1954-01-04 00:00:00.

Structured Monograph

Clinical summary

Approval overview TETRACYN is listed in Drugs@FDA under application 060285 (ANDA). Marketing status: Discontinued Active ingredient PROCAINE HYDROCHLORIDE; TETRACYCLINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 40MG/VIAL;100MG/VIAL Sponsor PFIZER Submission history Latest submission status date: 1954-01-04 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
TETRACYN (PROCAINE HYDROCHLORIDE; TETRACYCLINE HYDROCHLORIDE) | Drug Monograph | MedicHelpline